A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer.
about
A unified model of the hierarchical and stochastic theories of gastric cancer.Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer: A Randomized, Controlled Study.Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence.Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosisEarly Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis
P2860
A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A phase II study of catumaxoma ...... ily resectable gastric cancer.
@en
type
label
A phase II study of catumaxoma ...... ily resectable gastric cancer.
@en
prefLabel
A phase II study of catumaxoma ...... ily resectable gastric cancer.
@en
P2093
P2860
P1433
P1476
A phase II study of catumaxoma ...... ily resectable gastric cancer.
@en
P2093
Alexander Stein
Alexis Ulrich
Carsten Bokemeyer
Christoph Schuhmacher
Colin Krüger
Djordje Atanackovic
Ewald Wöll
Karsten Ridwelski
Ramona Fischer
P2860
P2888
P304
P356
10.1007/S10120-014-0423-6
P50
P577
2014-09-12T00:00:00Z